Description Pursuant to Section 3-05 of the New York City Procurement Policy Board Rules, the Department of Health and Mental Hygiene (DOHMH) intends to enter into negotiations for a three-year agreement with DrFirstcom Inc ("DrFirst") to provide iPrescribe Enterprise, including implementation and ongoing customer service support. iPrescribe Enterprise is an electronic prescribing solution that enables healthcare providers to prescribe both legend drugs and controlled substances safely and efficiently. DOHMH will utilize this prescribing solution in the Public Health Clinics for state-mandated e-prescriptions. DOHMH has determined that Dr. Firstcom Inc. is the sole source provider. iPrescribe Enterprise is exclusively developed, sold, and supported by DrFirst. There are no third-party agents, resellers, or distributors authorized to offer this product. All purchases must be made directly through DrFirst. Any firm that believes it can legally provide this web-based solution for e-prescribing, including implementation and ongoing customer service support, is invited to submit an Expression of Interest directly to this RFI- EPIN 81626Y0823 no later than 5/4/2026. If you need additional assistance with PASSPort, please
